Agencourt Bioscience Overview

  • Year Founded
  • 2000

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 1

Agencourt Bioscience General Information

Description

Provider of nucleic acid purification products and genomic services intended for life science research. The company's products include solid phase reversible immobilization (SPRI) reagents, a PCR1 purification system that delivers DNA, a dye-terminator removal process system, a paramagenetic bead-based plasmid purification system, and a genomic DNA isolation reagent kit, enabling clients to avail genomic, functional genomic and proteomic discovery services.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • 500 Cummings Center
  • Suite 2450
  • Beverly, MA 01915
  • United States
Primary Industry
Other Healthcare Services
Acquirer
Beckman Coulter
Vertical(s)
Life Sciences
Corporate Office
  • 500 Cummings Center
  • Suite 2450
  • Beverly, MA 01915
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Agencourt Bioscience Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Agencourt Bioscience‘s full profile, request access.

Request a free trial

Agencourt Bioscience FAQs

  • When was Agencourt Bioscience founded?

    Agencourt Bioscience was founded in 2000.

  • Where is Agencourt Bioscience headquartered?

    Agencourt Bioscience is headquartered in Beverly, MA.

  • What industry is Agencourt Bioscience in?

    Agencourt Bioscience’s primary industry is Other Healthcare Services.

  • Is Agencourt Bioscience a private or public company?

    Agencourt Bioscience is a Private company.

  • What is the current valuation of Agencourt Bioscience?

    The current valuation of Agencourt Bioscience is .

  • What is Agencourt Bioscience’s current revenue?

    The current revenue for Agencourt Bioscience is .

  • When was Agencourt Bioscience acquired?

    Agencourt Bioscience was acquired on 27-Apr-2005.

  • Who acquired Agencourt Bioscience?

    Agencourt Bioscience was acquired by Beckman Coulter.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »